ClinicalTrials.gov
public full text
Public Domain
CX3CR1+T Cell Predict Immunotherapy Efficacy
This study aimed to evaluate the correlation between the proportion of flow-sorted CX3CR1+T cells in peripheral blood and the CX3CR1+T-specific gene signature and the efficacy of immunotherapy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Human CD1c-autoreactive T cells recognise <i>Mycobacterium tuberculosis</i> –infected antigen-presenting cells and display cytotoxic effector programmes#273220
- Association of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study#125818
- Combined Molecular B Cell and T Cell Compatibility Analysis for Enhanced Immunological Risk Stratification in Kidney Transplantation / Matthias Niemann#1038091
- Microfluidic models for adoptive cell-mediated cancer immunotherapies#1175228
- Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma#900512
Record · ID 883125
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive